Introduction
Tetracyclines, among the most commonly prescribed anti-9,10). This wide array of biological activities has resulted in the widespread application of tetracycline-based therapy in biotics, also display a number of independent, pleiotropic activities on inflammatory and immune processes. They have inflammatory disorders such as periodontitis and rheumatoid arthritis (7, 13, 14) . been shown to specifically decrease levels of inducible NO synthase in activated macrophages by regulating the stability In a number of studies, tetracyclines have also been shown to decrease humoral immune responses in mice (15) (16) (17) . of its mRNA (1, 2) and to inhibit phospholipase A2 (3). Cyclooxygenase-2-mediated prostaglandin synthesis is also differMoreover, minocycline treatment reduced serum levels of rheumatoid factor and total Ig in rheumatoid arthritis patients entially affected by various tetracyclines (4, 5) . Finally, tetracyclines can specifically inhibit the expression, activation (13, 14) . Tetracyclines have also been reported to suppress lymphocyte proliferation to mitogens and cytokine secretion from pro-enzyme precursor, as well as the enzymatic activity of metalloproteinases (MP) (6-8, reviewed in 9,10). MP inhibiin vitro, although the effect was variable and observed in only some systems (18-24). The complexity of the tetracyclines' tion is in part responsible for the tetracyclines' ability to modulate secretion of soluble factors released by proteolytic pleiotropic effects has hampered the study of the actual mechanisms responsible for their immunosuppressive activity, ectodomain shedding, such as tumor necrosis factor (TNF)-α (11) and Fas ligand (12), and to reduce the destruction of which have remained elusive. Tetracyclines, in particular doxycycline, are commonly used connective tissue during severe inflammation (reviewed in experimentally in cell lines and transgenic mice as regulators of switched cells was quantified using CellQuest software in eight to 16 independent LPS culture experiments, depending of artificial inducible/repressible transcription systems (25) (26) (27) . Despite the considerable amount of evidence pointing on the isotype, and three independent experiments for anti-CD40/IL-4 cultures; specific gates were drawn according to to specific activities of tetracyclines in eukaryotic organisms, the doxycycline-regulatable systems have become widely the distribution of isotype-positive cells in inducing versus non-inducing conditions (e.g. LPS versus LPS/IL-4 for IgG3). utilized because of their purported lack of significant pleiotropic effects. We have conducted a series of control experi-[ 3 H]Thymidine incorporation was measured at 48 h of culture, using flat-bottom 96-well plates (starting concentraments to establish the effect of doxycycline treatment on our model system, i.e. in vitro activated primary mouse B tion, 10 5 cells/well) with 1 µCi/well [ 3 H]thymidine for 12-16 h. lymphocytes, as a preliminary step to establishing such inducible systems for the study of B cell activation. The results
Analysis of Ig secretion we present here demonstrate that tetracyclines display several specific and dramatic inhibitory effects on B cell function C57Bl/6 lymphoblasts (from day 5 LPS cultures with or without doxycycline) were washed in PBS and resuspended at 10 6 in vitro at concentrations commonly achieved during antibiotic therapy and comparable to those used in inducible translive cells/ml in fresh culture medium with or without doxycycline. These secondary cultures were incubated for another genic systems.
24 h, after which supernatants were collected and analyzed by ELISA using polyclonal anti-IgM antibodies (Southern Methods Biotechnology Associates) on Dynatech Immulon I plates.
Reagents and cell lines RNA analysis Doxycycline (1 mg/ml in water; Sigma, St Louis, MO), chemically modified tetracyclines (CMT; 1 mg/ml in 90% ethanol, Total RNA was extracted using the Trizol reagent (Gibco/BRL, 10% DMSO; kindly provided by Collagenex Pharmaceuticals, Carlsbad, CA). Northern blot analysis was performed by Newton, PA), the hydroxamate KB8301 (10 mM in DMSO; electrophoresis of 10 µg of total RNA on 2% formaldehyde, PharMingen, San Diego, CA) were all stored aliquoted at 1% agarose gels, transfer onto ZetaProbe nylon membranes -20°C. Human tissue inhibitor of metalloproteinases (TIMP)-(BioRad, Hercules, CA) and hybridization to random-primed 1 and -2 (0.5 mg/ml in PBS; Chemicon International, Temecula, 32 P-labeled probes (see legends for probe description). Multi-CA) were stored at -80°C.
probe RNase protection assays (RPA) were performed using the mMyc probe template set with the Riboquant in vitro In vitro activation assays transcription and RPA kits (PharMingen) on RNAs from two independent experiments, with reproducible results. Amounts Splenocytes were derived from 4-to 16-week-old C57Bl/6 or BALB/c mice housed in specific pathogen-free conditions in of 15 µg of total RNA/sample were used in each assay. The RPA products were separated by 6 M urea-PAGE and the URMC Vivarium. CD19 ϩ B cells were purified in some experiments using a Miltenyi Biotec (Bergisch-Gladbach, detected by autoradiography for 2-16 h. For RT-PCR, 5 µg of total RNA from the indicated sources Germany) Midi-MACS magnetic sorting apparatus and columns with either directly conjugated anti-CD19 beads or were reverse transcribed using random hexamer primers and Superscript reverse transcriptase (Gibco/BRL). After digestion FITC-conjugated anti-CD19 antibody and anti-FITC beads, according to the manufacturer's protocols. A single purificawith RNase H, the cDNA was subject to PCR using the following primers: secretory C µ tail: 5Ј-CACACTGTAtion step consistently yielded 95-98% B220 ϩ , IgM ϩ cells. In some experiments, the cells were loaded prior to culture CAATGTCTCCCT-3Ј and 5Ј-AAAATGCAACATCTCACTCTG-3Ј; membrane C µ tail: 5Ј-TCCTCCTGAGCCTCTTCTAC-3Ј and with the vital fluorescent dye 5-(and 6-)carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, 5Ј-CCAGACATTGCTTCAGATTG-3Ј. Co-amplification reactions were set up with both sets of primers, and PCR aliquots Eugene, OR), which allows estimation of division cycles of proliferating cells, as described (28, 29) .
were withdrawn at 23, 25, 27, 29 and 31 cycles (1 min denaturation at 94°C, 30 s annealing at 55°C and 1 min Splenocytes or CD19 ϩ B cells were cultured for 5 days in complete RPMI medium, 10% FCS plus activators-either extension at 72°C each) to control for linear amplification of both products. Amplified fragments were run on a 1.5% 20 µg/ml bacterial lipopolysaccharide (LPS; Sigma)/10 µg/ml dextran sulfate or 2 µg/ml anti-CD40 antibody (clone HM40-agarose gel and visualized by ethidium bromide staining. 3; PharMingen)-with or without 25 ng/ml recombinant mouse IL-4 (R & D Systems, Minneapolis, MN). The cell concentration Digestion-circularization PCR (DC-PCR) was adjusted daily to~10 6 /ml. All additional reagents were added from day 0 of culture at the concentrations indicated Genomic DNAs were extracted from day 4 LPS B cell blasts using the Qiagen (Valencia, CA) DNeasy kit and digested in the text. At day 5, the B cell blasts were stained for expression of surface markers and Ig heavy chain isotypes to completion with the indicated restriction enzymes. The digested samples were then re-ligated in diluted conditions using fluorochrome-conjugated mAb (PharMingen and Southern Biotechnology Associates, Birmingham, AL) (see (360 ng/200 µl reaction) which favor re-circularization of the products, precipitated and resuspended, and 100 ng aliquots legends for antibody description). Stained cells were analyzed by flow cytometry on a Becton Dickinson (Mountain View, CA)
were subject to DC-PCR amplification. Published primers and conditions were used for nested PCR of EcoRI-cut and reFACSCalibur instrument using CellQuest software. The fraction circularized S µ -S ε rearranged fragments (30) and for PCR of B cells was also significantly diminished (14% of normal MFI). the non-rearranging acetylcholine receptor (AchR) gene, as Note, however, that this decrease, unlike that in IgG isotypean internal control (31) . For S µ -S γ3 rearrangements, genomic positive cells, indicates a lower level of IgE in the superDNAs were digested with XbaI, and the religated product natant, rather than lower numbers of IgE-switched cells, subjected to a nested PCR reaction using first the primer pair because of passive IgE binding to the low-affinity FcεRI, 5Ј-GGTCAAACTTGTTACAGCCGTT-3Ј and 5Ј-ACTGAGTGT-CD23. CCTCTCAACCACC-3Ј (30 cycles, 1 min at 94°C, 90 s at
In agreement with a block of class switching in doxycycline-55°C, 2 min at 72°C), followed by the primer pair 5Ј-ATGCACAtreated cells, lower numbers of surface IgM dull lymphoblasts GAGGGAAGGAAGAAG-3Ј and 5Ј-CCAGCATGTTCAACCG-(which include isotype-switched cells) were observed (40% of AAATAA-3Ј (30 cycles, 1 min at 94°C, 1 min at 58°C, 90 s at normal), while IgM bright cells were correspondingly increased 72°C). Internal control for this reaction was a DC-PCR assay ( Fig. 1) . Furthermore, splenocytes activated with anti-CD40 for the Delta-like 3 Notch ligand gene (GenBank accession and IL-4 displayed a similar block in expression of IgG1 no. AF068865), using the primers 5Ј-ATAACGTGTTTGTGG-(4-fold) and IgE (6.3% of normal MFI) in the presence of AAGTTAGAGGA-3Ј and 5Ј-CGATGATAGAGAAGGGACAAdoxycycline (Fig. 2) ; thus, the inhibitory mechanism is not GATAGA-3Ј. All products were separated on a 1.5% agarose LPS specific. Class switch inhibition by doxycycline was gel and visualized by ethidium bromide.
found to be dose dependent, with a small but detectable effect observed in most cases at concentrations as low as 1.25 µg/ml doxycycline ( Fig. 2 ). Secondary isotype expression was also affected in doxyResults cycline-treated magnetically sorted CD19 ϩ B lymphocytes Doxycycline significantly inhibits Ig secretion and class switch-(Ͼ95% B220 ϩ , IgM ϩ cells) and in splenic B cells from TCR ing in vitro βδ -/-T cell-deficient mice, strongly suggesting a B cellintrinsic mechanism for the inhibition (not shown). Primary mouse splenocytes were cultured in medium conAs a second parameter in B cell activation, we analyzed taining LPS/dextran, with or without the addition of IL-4, in the the ability of LPS-activated lymphoblasts to secrete Ig. Day presence of increasing concentrations of doxycycline (in the 5-activated B cells from control and doxycycline-treated cultherapeutically effective range of 1.25-5 µg/ml). At day 5, the tures were washed and cultured at 10 6 cells/ml for a further activated B cell blasts were harvested and analyzed for 24 h in fresh medium. ELISA on the supernatants showed expression of Ig isotypes by flow cytometry.
that doxycycline-treated cells secreted~10-fold less IgM than Treatment with 5 µg/ml doxycycline resulted in a significant control cells (Fig. 3A) . Since surface IgM ϩ cells are actually decrease in the fraction of lymphoblasts positive for secondary more abundant in doxycycline cultures because of the block isotypes ( Fig. 1) . On average, a 10-fold decrease was in class switching, the difference on a cell basis is likely even observed for IgG3 expression, 2-fold for IgG1 and 4-fold for IgG2b. Similarly, surface staining for IgE in LPS/IL-4-treated more pronounced. Doxycycline-treated and control day 5 LPS lymphoblasts were plated at 10 6 cells/ml in fresh medium (supplemented with 5 µg/ml doxycycline when appropriate), and IgM secretion was measured 24 h later by ELISA on the culture supernatants. In three independent experiments with activated B cell blasts a 5-to 10-fold suppression in IgM production is observed in doxycycline-treated cells. The detection limit in these experiments was 20 ng/ml (dotted line).
expression even in the fraction of doxycycline-treated cells that have undergone the highest number of cell divisions (Fig. 4C) . Thus, while doxycycline can partially inhibit cell proliferation in vitro, this is not the cause of class switch line-treated cells and controls ( Fig. 5 and not shown); however, the fraction of cells expressing the Syndecan-1/CD138 plasma cell marker was decreased by~3-fold (over five experiments) (Fig. 5) .
Doxycycline has only marginal effects on expression of activation markers and cell proliferation Doxycycline inhibits class switch recombination Because both terminal B cell differentiation and, especially, class switching have been correlated with cell division in vitro,
Class switch recombination is blocked by mutation of the activation-induced deaminase (AID) gene, either in human we assessed the ability of doxycycline to suppress cell proliferation of LPS-stimulated B cells. Both [ 3 H]thymidine autosomal hyper-IgM syndrome patients or in gene-targeted mutant mice (32, 33) . Using Northern blot analysis, we found incorporation assays at day 2 of culture and direct measurement of cell division using vital CFSE staining indicated a no significant differences in AID mRNA levels between treated and control RNA samples (Fig. 6A) , ruling out an effect of small, variable decrease in proliferation of doxycycline-treated cells. Specifically, doxycycline suppressed thymidine incorpdoxycycline on AID gene transcription. Also required for class switching is the induction of germline oration in LPS cultures to 87 Ϯ 23% of controls in seven independent experiments (Fig. 4A) . Treated cells also genertranscripts from the heavy chain constant region genes targeted for recombination (reviewed in 34). Northern blot anaally displayed higher day 5 CFSE staining levels than controls, suggesting that they underwent a lower number of cell lysis showed, however, similar levels of steady-state levels of germline transcripts in doxycycline-treated and control divisions (Fig. 4B) . However, in several sets of experiments no significant decrease in proliferative capacity was observed.
cultures (Fig. 6A) , suggesting that doxycycline inhibits a later stage in the class switch process. We therefore used a DCMost importantly, there is no correlation between the degree of cell proliferation and class switch inhibition. In fact, double PCR assay to establish whether actual switch recombination takes place in doxycycline-treated B lymphocytes. In this CFSE/IgG3 staining reveals a deficiency in secondary isotype panied by the induction of expression of the Blimp-1 gene, which is able to promote the differentiation of surface Ig ϩ cell lines into Ig secretors (35) . During late B cell activation, Blimp-1 up-regulation directly represses c-myc transcription, while assay, genomic DNA fragments spanning rearranged switch expression of the myc antagonist mad-4 and of the secretory regions are generated by restriction enzyme digestion and component of polymeric Ig, J chain are induced (35) (36) (37) . We recircularized by ligation in diluted conditions. The junction therefore analyzed the expression of these genes using of the circularized fragments can be amplified by PCR using Northern blot analysis and RNase protection. In agreement primers mapping 5Ј of the S µ region and 3Ј of the target S with the decrease in Ig secretion, doxycycline-treated in vitroregion (31); because these primers would map on different activated B cell blasts expressed 3-to 5-fold less Blimp-1 circularized fragments on unrearranged DNA, the amplificatranscripts and Ͼ10-fold less J chain transcripts compared tion is specific to switched cells. DC-PCR analysis shows to controls (Fig. 6B) , and failed to up-regulate mad-4 transcripa Ͼ20-fold decrease in the amount of S µ -S γ 3 rearranged tion (Fig. 6C) . A small but reproducible increase in c-myc fragments in doxycycline-treated cells (Fig. 7) . Similar results mRNA levels (~50%) was also observed (Fig. 6B and C) . C µ were obtained for S µ -Sε DC-PCR assays (not shown). Together transcript expression is also only marginally affected by with the germline transcript expression data, these findings doxycycline treatment in LPS cultures (60-80% of normal) (Fig.  strongly suggest that the switch block in doxycycline-treated 6B), ruling out a major modulation of IgH locus transcription by cells occurs at, or immediately before, the recombination stage.
doxycycline. Our data suggest therefore that doxycycline may inhibit the expression and directly blocking MP activity (6,8). MP are ubiquitously expressed and are known to play important roles entire terminal differentiation program, resulting in coordinate alterations of an entire set of genes and markers (Blimp-1, in lymphocyte development and function; therefore, we tested other known inhibitors for their activity on B cells. mad-4, J chain and Syndecan-1) characteristic of the later stages of B cell activation.
First, we analyzed the effect of three tetracycline analogs lacking antibiotic activity: CMT3 and CMT8, which retain MP inhibitory activity, and CMT5, which does not (reviewed in Other MP inhibitors suppress class switching in activated 10). Of the three reagents, CMT3 and CMT8 were able to B cells inhibit class switching in vitro, at concentrations even lower than doxycycline (1.25 and 2.5 µg/ml respectively); CMT5, As discussed above, tetracyclines display several pleiotropic effects on mammalian cells, only a handful of which have on the other hand, did not display any effect at concentrations up to 7.5 µg/ml (Fig. 8A ). been thoroughly characterized. A significant property of tetracyclines is their ability to inhibit matrix MP, by reducing mRNA
We then analyzed some tetracycline-unrelated MP inhib- itors: TIMP-1 and -2, and the hydroxamate KB8301. Note that TIMP are rather selective inhibitors, each acting on a restricted subset of MP, while both tetracyclines and hydroxamates have a wider spectrum of activity. Normal expression of secondary isotypes was observed in cultures treated with the endogenous inhibitors TIMP-1 and -2 (not shown), but KB8301 at a concentration of 20 µM inhibited class switching to an extent comparable to 5 µg/ml doxycycline (Fig. 8B) . However, at this concentration no decrease in Ig secretion was observed in KB8301-treated cells (not shown).
Because tetracyclines (excluding, notably, CMT5) and hydroxamates can chelate divalent cations, including Zn 2ϩ and Ca 2ϩ , the block in class switching could potentially be due to non-specific interference with calcium-mediated signaling. To rule out this possibility, we supplemented LPS cultures with specific calcium chelators (0.5 mM EGTA or 2.5 µM BAPTA-AM, both the highest possible non-cytotoxic concentrations in these cultures); no effect on class switching tetracyclines CMT3 (1.25 µg/ml), CMT5 (7.5 µg/ml) and CMT8 (2.5 µg/ml). CMT3 and CMT8, which retain MP inhibitory activity, are able to suppress class switching (lower numbers of IgG3 ϩ and IgM low cells), while CMT5, which has lost this activity, has no effect. (B) Top, control culture; center, doxycycline-treated culture; bottom, KB8301-Discussion treated culture. The hydroxamate KB8301 inhibits class switching to Following the discovery of a striking variety of non-antibiotic an extent comparable to that of doxycycline.
properties of tetracyclines, the therapeutic indications for these drugs have been successfully extended in the past 15 years to rheumatoid arthritis and periodontal disease, and potential new applications are being explored for conditions 1 as well as the production and activity of enzymes directly involved in tissue destruction, such as the matrix MP collaas diverse as stroke, aortic aneurysm, endotoxic shock and metastatic cancer (reviewed in 7,9,10). This is certainly in genase and stromelysin (reviewed in 7,9,10). Evidence of more subtle but significant effects of tetracylarge part due to the tetracyclines' ability to inhibit the release of pro-inflammatory mediators, including NO, TNF-α and ILclines on immune function is also well established, although less clearly characterized. In this report, we show that doxyclass switch recombination level. It is possible that differences in the specificity of batimastat, KB8301 and tetracyclines for cycline can have specific, direct effects on B lymphocytes, selectively blocking some of the activities characteristic of individual MP, or in their bioavailability (unlike doxycycline, hydroxamates are highly insoluble), may be responsible for activated lymphoblasts and terminally differentiated B cells. This novel finding provides a key for interpretation of some the variability in their effect on different aspects of B cell activation. Further investigation of these discrepancies may of the activities of tetracyclines on the immune system.
While doxycycline-treated B cells have on average slightly reveal whether a single or multiple pathways are involved in the inhibition of class switching and Ig secretion by these lower proliferative capacity than controls, they are able to upregulate specific activation markers, and to express AID and compounds. Among the most appealing candidates for our observations heavy chain germline transcripts. These observations indicate that early activation events are largely unaffected by doxycycare members of the TNF/TNF receptor family, including TNF-α itself, Blys/BAFF/zTNF4/Tall-1/THANK and its receptors TACI line treatment.
Unlike the events occurring during early B cell activation, and BCMA, as well as CD30-CD30 ligand, which have all been shown to profoundly affect B cell function in vivo and terminal B cell differentiation is strikingly affected by doxycycline, with significant decreases in Ig secretion, J chain mRNA in vitro (47,54-60, reviewed in 61,62). However, while these ligand-receptor pairs are generally thought to act in trans, levels and Syndecan-1 expression (three key plasma cell markers). The entire differentiation program appears to be either by secretion or cell-cell contact, our results suggest a B cell-intrinsic mechanism for the activity of MP inhibitors. targeted, since doxycycline treatment also decreases expression of the Blimp-1 gene, considered a master transcription Specific experiments will be required to establish whether homotypic interactions between activated B cells or autocrine factor for terminal B cell differentiation (35) , and of mad-4, also induced upon terminal differentiation (37) . Consistently, stimulation through any of these pathways plays a role in the effect of MP inhibitors on class switching. c-myc expression levels, which are normally down-regulated in terminally differentiated B cells by direct Blimp-1-mediated
The MP-inhibitory activity of tetracyclines and hydroxamates depends at least in part on their ability to interfere with the repression (36) , are slightly (51 Ϯ 11% over three experiments) but reproducibly higher in the presence of doxycycline.
Zn 2ϩ ion in the MP active site (reviewed in 10,63). Indeed, loss of the ability to chelate divalent cations, such as in CMTIn contrast to terminal B cell differentiation, inhibition of class switching appears to be affected at the recombination 5, abrogates the tetracyclines MP-inhibitory activity (10,63). Because neither EGTA nor BAPTA-AM have any effect on stage and is not accompanied by inhibition of expression of either germline transcripts or the AID gene. Whether this is a class switching in LPS cultures, non-specific effects on Ca 2ϩ -mediated signals can be ruled out. It is possible, however, direct effect on the recombination mechanism or indirectly mediated through some unknown intermediate factor remains that tetracyclines and hydroxamates may also interfere with the activity of other metalloproteins, such as zinc-finger tranto be investigated. Both in vitro class switching and terminal B cell differentiation are known to be correlated with the scription factors, DNA repair enzymes or histone deacetylase (64). Interestingly, the cytidine deaminase activity of AID also number of cell divisions (28, 29, 38) , suggesting perhaps that, although largely independent phenomena, they may share has been shown to be Zn 2ϩ dependent (65). Although the exact role of AID and cytidine deamination in class switching some early common induction pathway. In any case, our data show that the small, variable effect of doxycycline on is still unknown, the possibility of inhibition of AID function by doxycycline is particularly intriguing. proliferation is most likely not responsible for the observed effects.
Taken together, our observations suggest that the immunosuppressive effects of tetracyclines on humoral immune funcThe ability of other MP inhibitors to mimic doxycycline's effect on class switching is particularly interesting and may tion in vivo, as judged by both reduction of basal total Ig and rheumatoid factor levels in rheumatoid arthritis patients as suggest a previously unrecognized role of these enzymes in B cell activation. MP have already been implicated in many well as decreased responses in immunized mice, are at least in part due to a direct effect on B lymphocytes. aspects of lymphocyte development and function: among their substrates are several members of the TNF/TNF receptor Another important implication of these studies concerns the use of doxycycline-inducible transcription systems for family, CD43, CD23, L-selectin (12,39-47, reviewed in 48). MP are also involved in the processing of Notch family in vitro and in vivo transgenic studies. In general, it is assumed (and advertised) that doxycycline is devoid of pleiotropic receptors and their ligands (review in 49), and are generally expressed in a specific and regulated fashion in B and T
effects. Yet, in vitro systems using the tetracycline-dependent activator rtTA require doxycycline concentrations up to 1 µg/ cells (50-52). Indeed, it has already been reported that batimastat, another hydroxamate, is able to inhibit IgE, but ml (26) , very close to the effective dose observed in our experiments. In addition, in vivo transgenic experiments are not IgG, production in activated human and mouse B cells (43, 46) . In that case, the effect was correlated with the ability performed feeding the mice water supplemented with as much as 200 µg/ml doxycycline (27) . Assuming a similar of this compound to inhibit the shedding of CD23, thereby amplifying a well-characterized negative feed-back loop on pharmacokinetics of doxycycline in mice and humans, this dose is actually higher than what normally given to patients, IgE secretion (53). Although we observe a similar effect of doxycycline on CD23 expression in LPS/IL-4-activated B cells, whose serum doxycycline concentration can rise to Ͼ8 µg/ ml during treatment (66). The possibility of experimental this mechanism cannot fully explain our observations, since in our hands other isotypes besides IgE are affected, and artifacts in such systems is further amplified by the potential synergism between the multiple activities of doxycycline because we showed that doxycycline can directly act at the should certainly serve as a cautionary note regarding the 6 Greenwald, R. A., Golub, L. M., Lavietes, B., Ramamurthy, N. S., application of these assays to complex experimental systems Gruber 
